We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has obtained Highly Satisfactory results (with a 100% accuracy for qualitative detection of all QCMD blinded samples, including with lowest viral load) in the context of the QCMD 2020 Coronavirus Outbreak Preparedness EQA Pi…

A unique and flexible solution adapted to all virology and microbiology laboratories LUXEMBOURG CITY (Luxembourg), METZ (France) — May 18th, 2020 — Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its DeepChek®-HIV assays, now available for in-vitro diagnostics. Intend…

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 7— Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its UltraGene® Combo2Screen SARS-CoV-2 assay is now available for in-vitro diagnostics use. This test is intended to be used for the qualitative detection of nuc…

We did in March 2020 an external clinical validation with the French National Reference Centre for Covid-19 (CNR). The validation was in two phases. Clinical samples were tested both with the CNR’s RT-PCR reference method (IP2/IP4) and the UltraGene Combo2Screen SARS-CoV-2 Assay. The two phase…

NEWBURYPORT, MA – May 1, 2020: AdvancedDx Biological Laboratories USA Inc. (ABLDx), a virologic diagnostic solutions company, announced today its official launch in the U.S. to commercialize solutions that will advance public health in the Americas. The company will be focused on fighting the COVID-…

We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has been validated by the Quality Control for Molecular Diagnostics (QCMD). The QCMD is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation, providing wide-ranging quality a…